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ASSOCIATION OF HL-A 5ANDIMMUNE RESPONSIVENESS
IN VITRO TO STREPTOCOCCAL ANTIGENS*
BY LEONARD J . GREENBERG, ERNEST D . GRAY, AND EDMOND J. YUNIS
(From the University of Minnesota Hospitals, Department of Laboratory Medicine and Pathology,
and the Department of Pediatrics and Biochemistry, Minneapolis, Minnesota 55455)
Studies in mice have provided data linking immune responsiveness (1-3),
autoimmune disease (4), and resistance or susceptibility to virus infection and
neoplasia (5, 6) to the murine majortransplantation (H-2) antigen complex . The
association between a transplantation antigen, a specific antibody response, and
severity of disease observed in the case of murine autoimmune thyroiditis (4) has
given credence to the notion that histocompatibility-linked immune response
genes may play an important role not only in resistance or susceptibility to
autoimmune disease, but also to neoplasia and disease in general .
There studies have led to the presumption that the observed associations are
meaningful for survival and therefore have been preserved in evolution . As a
consequence, many investigators have searched for association between human
histocompatibility antigens (HL-A) and susceptibility or resistance to specific
diseases . Several examples of HL-A-associated diseases have been described : the
4C complex and Hodgkin's (7-10), HL-A2-12 in acute leukemia and lymphoma
(10-14), W15 in systemic lupus erythematosus (15, 16), HL-A 1-8 in chronic
hepatitis (17), HL-A 3-7 in multiple sclerosis (18), W17 in psoriasis (19, 20), and
W27 in Reiter's syndrome and ankylosing spondylitis (21-23) . In the case of
Hodgkin's disease and acute leukemia and lymphoma the correlations vary from
population to population and are negative in some cases . Furthermore, in those
populations where there is evidence of strong associations there are many
patients who do not carry the HL-A type in question . However, in the studies
dealing with chronic hepatitis, multiple sclerosis, psoriasis, and ankylosing
spondylitis very striking HL-A associations have been observed . The most likely
explanation for this dilemma probably derivesfrom the fact that susceptibility or
resistance to disease is controlled by multiple genes including HL-A genes . If
such is the case then expression of a disease state could reflect linkage
disequilibrium between particular HL-A genes and genes closely linked to HL-A
and consequently HL-A antigens would only serve, in some instances, as markers
for the genes that are actually involved . Whatever the case may be the
development of methods for identifying specific immune responses in humans
will be of prime importance in the establishment of these associations . Toward
this end we have been studying a large control population with respect to
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cell-mediated immunity in vivo by measuring delayed-type skin reactions to
selected antigens ; and in vitro, by the blastogenic response oflymphocytes to the
same antigens . The marked variation in response to one of these antigens,
streptokinase-streptodornase (SK/SD), 1 prompted us to study this phenomenon
in detail . In this study we provide evidence for the association of HL-A 5 with
immune responsiveness in vitro to streptococcal antigens .
Materials and Methods
Test Lymphocytes .
￿
Peripheral lymphocytes were isolated and purified (24) from 217 randomly
selected individuals ranging in age from 25 to 65 yr . These individuals were judged to have normal
immune function by the following criteria : capacity to stimulate and respond in mixed leukocyte
cultures ; normal response to phytohemagglutinin, concanavalin A, and pokeweed mitogen; normal
immunoglobulin levels ; normal proportion of peripheral bloodB cells as determined by immunofluo-
rescent staining of cell surfaceimmunoglobulins andby complement receptors ; andanormal range of
"T" cells as indicated by T-cell rosettes and a T-cell cytotoxicity assay .
HL-A Serotyping . HL-A antigens were determined with a standard two-stage dye exclusion
microcytotoxicity test (25) using a panel of 115 well-characterized antisera capable of detecting all
defined HL-A and most W specificities .
Streptococcal Antigens .
￿
Theantigen preparation employed in this study (SK/SD) was obtained
from American Cyanamid Co ., Lederle Laboratories Div., Pearl River, N. Y. Although this type of
preparation is rather crude, it is one of therecommended antigens (26) commonly used as a skin test
forthe assessment of pre-existing immunity . In order to minimize heterogeneitywe obtained a large
quantity of antigen preparation distributed in 2-ml ampulesfrom a single lot . The contents of each
ampule were dissolved in 2 ml sterile distilled water assayed for protein (27) and kept at 4°C.
Although this stock solution wasstable at 4°Cforapproximately 2 mo, extensive testingnecessitated
preparing of new stock solution on a weekly basis . Dilutions were made each day in culture medium
immediately before use. Streptococcal nucleases were isolated by the method of Marker and Gray
(28) .
Assay System .
￿
10 5 purified lymphocytes were incubated in triplicate in a COY environment at
37°C in Microtest II (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) culture plates . Each well
contained 0.2 ml of Eagle's minimal essential medium with addition of penicillin, streptomycin,
L-glutamine, pooled human serum (20% vol/vol), and varying concentrations of SK/SD. The same
pool ofhuman serum and employed throughout this study . After 120 h, 50 dal of tritiated thymidine
( ['H]TdR) solution (1 wci/ml) wasadded to each well . Theplates were incubated an additional 24 h,
harvested, and assayed for radioactivity .
Results
Test lymphocytes incubated in vitro with varyingconcentrations of streptococcal
antigens showed three types of response : (a) response over the entire range of
antigen concentrations ; (b) low response to only the highest antigen concentra-
tions; and (c) no response to any antigen concentration . The data is presented in
Fig . 1 in which the rate of incorporation of [3H]TdR is plotted as a function of
antigen concentration . It can be seen that lymphocytes from individuals defined
as responders (curve A) are reactive over a concentration range from 10 to 6,000
ng SK/SD/ml . The low responder (curve B) reactivity decreases rapidly with
decreasing antigen concentration reaching a minimum at 100 ng/ml, while the
nonresponders (curve C) do not react at any concentration of antigen. The
frequency ofHL-A antigens in the various population segments is shown in Table
I . Statistical analysis of these distributions by chi-square (Table 11) reveals that
`Abbreviations used in this paper: ['H]TdR, tritiated thymidine ; SK/SD, streptokinase-strepto-
dornase .LEONARD J. GREENBERG, ERNEST D . GRAY, AND EDMOND J . YUNIS
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FIG. 1 . In vitro response to streptococcal antigens . Triplicate cultures of 10 5 purified
lymphocytes were incubated in a CO, environment at 37°C . After 120 h 50 'Ul of [SH]TdR (1
pCi/ml) was added to each culture . The cultures were incubated an additional 24 h, harvested,
and assayed for radioactivity . Curves A, B, andC represent responders, low responders, and
nonresponders, respectively . Numbers in parentheses indicate the sample size and the vertical
bars represent the standard error of the mean .
the low and nonresponder populations have the same HL-A antigen frequency
whereas the incidence of HL-A 5 is significantly increased in the responder
population when compared to low responders alone (P = 0.0003) or to the
combined low and nonresponder population (P = 0.0001) .
The use of antigens such as SK/SD for the assessment of cell-mediated
immunity is predicated on the fact that thehealthyadult population, having had
prior immunologic experience with streptococcal antigens will react both in vivo
with a delayed-type skin reaction and in vitro by lymphocyte blastogenesis . Since
SK/SD is a mixture of proteins, it was surprising to find a relatively large number
of individuals that failed to respond in vitro . Furthermore, the striking
association between responsiveness and HL-A 5 might be expected from an
antigen of restricted heterogeneity rather than the heterogeneous preparation
used in this study . One possible explanation for the observed response pattern
might be that SK/SD, upon dilution, manifests only one effective stimulatory
component while at higher concentrations a more heterogeneous reactivity is
elicited . While definitive characterization of SK/SD stimulation will have to
await fractionation and purification, it has been established that SK/SD
contains only one nuclease,' i.e ., nuclease A . This fact and the availability of
purified samples of streptococcal nucleases A, B, C, and D allowed us to study
the blastogenic effects of these enzymes on the reactivity of lymphocytes from938
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TABLE II
Chi-square Analysis of HL-A Antigen Frequency Distribution
A, B, and C refer to responder, low responders and nonresponders, respectively. p values for all chi-squares above
4.000 are given . Numbers in parentheses refer to Pvalues corrected for the number of HL-A antigens . Corrected P
values less than 0.05 are given . Corrections were made using the following expression: P = 1 - (1 - p)", where p is
the uncorrected value and the exponent relates to the number of HL-A antigens studied .
responders and nonresponders to SK/SD . It can be seen in Table III that
lymphocytes from responders to SK/SD (II) have a significantly higher reactivity
to concentrations of nucleases A and D in the threshold range than do
lymphocytes from nonresponders (I) . In the case of nucleases B and C the
blastogenic reactivity is considerably lower; the threshold level for nuclease B is
10-fold higher than A, C, and D; and there is no apparent difference between
SK/SD responders (II) and nonresponders (I) . These data not only suggest that
the observed response pattern to SK/SD is mediated by nuclease A (streptodor-
nase) but support the idea that responsiveness is genetically controlled . In an
effort to rule out possible residual streptococcal infection as a cause of the
variation in response, serum antistreptolysin-O titers were measured in all
individuals studied . No statistical difference in titer was observed between
responders, low responders, and nonresponders . However, the possibility still
remains that antibodies against components ofSK/SD, present only in responder
lymphocytes, mediate the observed blastogenesis . In this context it is of interest
to point out that McCarty (29) foundconsiderable variation in antibody response
to nuclease A in scarlet fever patients . In a study of 90 patients, 34 showed
Antigen A vs . B P A vs . C P Avs. B + C P B vs . C
HL-A 1 0.0664 1.7660 0.4428 1.6293
HL-A2 1.8513 0.2583 1.4432 0.5171
HL-A3 0.4432 1 .4634 0.8574 0.5974
HL-A 9 0.3390 0.4889 2.6549 0.8168
HL-A 10 0.7354 0.2481 0.6578 0.0754
HL-A 11 1.1658 1 .4623 1.4328 0.1009
W19 0.6433 1 .7643 1.2087 0.6215
W28 0.4109 0.3472 0.5033 0.0085
HL-A 5 19.0321 0.00001 7.5870 0.01 21.0841 0.000004 0.3591
(0.0003) (0.0001)
HL-A 7 4.6482 0.05 4.8637 0.05 5.4432 0.025 0.1548
HL-A 8 1.5055 0.5761 1 .3836 0.1140
HL-A 12 2.1480 2.0675 2.5241 0.0516
HL-A 13 0.3740 0.1179 0.1389 0.8872
W5 1.1943 4.4361 0.05 2.6345 2.0315
W10 0.0265 1.6405 0.3597 1.9311
W14 1.8856 1.0794 2.1849 0.0082
W15 6.4652 0.025 2.7805 6.7275 0.01 0.1384
W16 1.6979 5.5914 0.025 2.9744 2.6776
W17 0.0139 0.2481 0.0049 0.4269
W18 0.0608 0.8443 0.0074 1.4105
W22 0.8918 - 0.6361 0.8063
W27 1.6979 0.4569 1.4065 0.3762940
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* Nonresponders to SK/SD .
$ Responders to SK/SD .
TABLE III
Blastogenic Response (cpm) to Streptococcal Nucleases in the
Threshold Concentration Range
significant antibody titers to nuclease A, 33 did not have measureable amounts of
this antibody during the course of the study, and the remaining individuals had
low titers, once again suggestive of a possible genetic control .
Discussion
The apparent association ofHL-A 5 with responsiveness in vitro to streptococcal
antigens is interesting for two reasons : (a) it may represent the first demonstra-
tion ofan in vitro probe with which to study immune response genes in general,
and (b) more specifically it may provide an in vitro model for studying
immunogenetic aspects of streptococcal disease .
Although the precise mechanism by which specific histocompatibility antigens influence
the susceptibility or resistance to disease is not known, Snell (30) has suggested the
following possibilities : the histocompatibility antigen of the cell surface might be a
receptor site for the attachment of an infectious agent ; an infectious agent might share
antigenic determinants with host histocompatibility antigens whereby the host would be
tolerant to these antigens ; and finally that histocompatibility antigens themselves are not
involved directly but the genes controlling susceptibility are linked to genes coding for
histocompatibility antigens. In the first two situations susceptibility would be dominant
in the heterozygote whereas in the third case resistance would be dominant in the
heterozygote .
HL-A phenotype
I*
NucleaseA
(0.09 U/ml)
Nuclease B
(0 .9 U/ml)
Nuclease C
(0.09 U/ml)
Nuclease D
(0.09 U/ml)
3, 7, 10 4,400 1,784 1,087 6,422
1, 2, 8, 10 7,947 2,442 841 6,073
9, W19, 7, W17 735 249 0 217
1, 3, 7 4,169 0 0 49
1, 2, W17, W18 9,452 1,766 741 4,324
X = 5,341 X = 1,248 X = 889 X = 3,417
II$
2, 9,W5 68,222 4,959 3,791 33,169
1, 11, 5 32,165 1,272 497 27,217
2, 3, 5, 7 41,989 898 0 16,344
2, 9, 5, 12 20,841 2,116 0 9,759
2, W19,5, W14 12,918 200 569 2,806
X = 35,227 X = 1,889 X = 1,619 X = 17,859
I vs . II
t 3.07 0 .7 1 .22 2.52
P <0.01 NS NS <0.025LEONARD J. GREENBERG, ERNEST D . GRAY, AND EDMOND J. YUNIS
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Of particular relevance to streptococcal disease is the observation that heat-killed group
AStreptococci have the ability to induce a state of altered reactivity to skin homografts in
guinea pigs (31) which may come about as a result of shared antigens or alterations ofthe
animal's antigens by the injected material . Efforts to relate this observation to problems
in humans revealed that the M protein from beta hemolytic group A Streptococcus
pyogenes type 1 completely inhibited the cytotoxic antibody activity of antisera to HL-A
1, 2, 3, 7, 8, and 9whereas analogousM proteins from types 3, 4, 5, 6, 12, and 14 had little
or no inhibitory activity (32) . The authors interpreted this data to mean that M1 protein
has a structure common to human histocompatibility antigens . In a more recent study
(33) M1 proteinwas found to stimulatehuman peripheral bloodlymphocytes in culture to
undergo a dose-dependent increase in DNA synthesis . However, the degree ofstimulation
was not related to the serum anti-M1 titer of the lymphocyte donor, the effectiveness of
M1 antigen in blocking the cytotoxic activity ofHL-A antisera, or to theHL-A phenotype .
The lack of agreement in these studies with respect to inhibition of cytotoxic HL-A
antibody activity makes one question the interpretation that M1 protein has significant
structural similarities to human histocompatibility antigens . Furthermore, the lack of any
HL-A association probably derives from an insufficient sample size (n = 9) .
Since streptococci appear to contain many substances capable of stimulating
blastogenesis in lymphocytes, it is quite possible that in some cases clear-cut
associations between HL-A antigens and immune responsiveness will be estab-
lished while in othercasesno association will be apparent . On the otherhand, the
lack of sufficient characterization of stimulatory material may provide an
element of confusion, whereby lymphocyte blastogenesis may be induced by only
one streptococcal component present as a contaminant of other preparations
(34) . This notion seems unlikely, however, in view of the marked difference in
reactivity observed in lymphocytes from responders and nonresponders to
different streptococcal nucleases (Table III) . The selective nature of the
nuclease-mediated blastogenesis in this study and the variation in antinuclease
A antibody levels observed by McCarty (29) in scarlet fever patients, if related,
provide a rational basis for postulating the existence ofa specific genetic control
mechanism governing immune responsiveness to streptococcal antigens which
appears to be linked to the major histocompatibility system . Recently, in vivo
studies from several laboratories have provided suggestive evidence for the
existence ofHL-A-linked immune response genes (35-38) . If histocompatibility-
linked immune response genes are important in determining susceptibility or
resistance to disease in general, then a search for associations will depend not
only upon the demonstration that specific immune response genes are indeed
linked to the major histocompatibility loci but also on the availability of
techniques for determining their phenotypic expression in man . The observed
association ofHL-A5 to in vitro blasttransformation by streptococcal antigens is
another step forward in this direction .
Summary
Lymphocytes, from randomly selected individuals having normal immune
function, when incubated in vitro with varying concentrations of streptococcal
antigens, responded in three ways : (a) response over the entire antigen
concentration range, i.e ., responders ; (b) low response to only the highest antigen
concentrations ; and (c) no response at any antigen concentration . Frequency942
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distribution analysis of these groups indicated that a significant association
occurred between the ability to respond and HL-A 5.
Received for publication 7 October 1974.
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